| Authors: |
Moll K; IBM Watson Health, 75 Binney St, Cambridge, MA 02142, USA. Electronic address: kmoll@us.ibm.com., Wong HL; U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, 10903 New Hampshire Avenue, Silver Spring, MD 20993-0002, USA., Fingar K; IBM Watson Health, 75 Binney St, Cambridge, MA 02142, USA., Zhou CK; U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, 10903 New Hampshire Avenue, Silver Spring, MD 20993-0002, USA., Lu M; Acumen LLC, 500 Airport Blvd, Suite 100, Burlingame, CA 94010, USA., Hu M; Acumen LLC, 500 Airport Blvd, Suite 100, Burlingame, CA 94010, USA., Hobbi S; IBM Global Business Services, 6710 Rockledge Dr, Bethesda, MD 20817-1834, USA., Burrell T; IBM Watson Health, 75 Binney St, Cambridge, MA 02142, USA., Baer B; U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, 10903 New Hampshire Avenue, Silver Spring, MD 20993-0002, USA., Simard J; Stanford University, Department of Epidemiology and Population Health at Stanford School of Medicine, 291 Campus Drive, Stanford, CA 94305, USA., Obidi J; U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, 10903 New Hampshire Avenue, Silver Spring, MD 20993-0002, USA., Chillarige Y; Acumen LLC, 500 Airport Blvd, Suite 100, Burlingame, CA 94010, USA., MaCurdy T; Acumen LLC, 500 Airport Blvd, Suite 100, Burlingame, CA 94010, USA; Stanford University, Department of Economics, 579 Jane Stanford Way, Stanford, CA 94305, USA., Anderson S; U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, 10903 New Hampshire Avenue, Silver Spring, MD 20993-0002, USA., Shoaibi A; U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, 10903 New Hampshire Avenue, Silver Spring, MD 20993-0002, USA. |
